Potential applications of nanocellulose-containing materials in the biomedical field by Halib, Nadia et al.
materials
Review
Potential Applications of Nanocellulose-Containing
Materials in the Biomedical Field
Nadia Halib 1, Francesca Perrone 2, Maja Cemazar 3 ID , Barbara Dapas 2, Rossella Farra 4,
Michela Abrami 4, Gianluca Chiarappa 4, Giancarlo Forte 5, Fabrizio Zanconati 6,
Gabriele Pozzato 6, Luigi Murena 6, Nicola Fiotti 6, Romano Lapasin 4, Laura Cansolino 7,
Gabriele Grassi 2,* and Mario Grassi 4 ID
1 Department of Basic Sciences & Oral Biology, Faculty of Dentistry, Universiti Sains Islam Malaysia, Level 15,
Tower B, Persiaran MPAJ, Jalan Pandan Utama, Kuala Lumpur 55100, Malaysia; nadia.halib@usim.edu.my
2 Department of Life Sciences, Cattinara University Hospital, Trieste University, Strada di Fiume 447,
I-34149 Trieste, Italy; fperrone116@gmail.com (F.P.); bdapas@units.it (B.D.)
3 Institute of Oncology Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia; MCemazar@onko-i.si
4 Department of Engineering and Architecture, University of Trieste, Via Valerio 6/A, I-34127 Trieste, Italy;
rfarra@units.it (R.F.); mikystars@hotmail.com (M.A.); gianluca.chiarappa@phd.units.it (G.C.);
romano.lapasin@dia.units.it (R.L.); mario.grassi@dia.units.it (M.G.)
5 Center for Translational Medicine, International Clinical Research Center, St. Anne’s University Hospital,
Pekarska 53, 656 91 Brno, Czech Republic; giaforte@gmail.com
6 Surgery and Health Sciences, Department of Medical, Cattinara Hospital, University of Trieste,
I-34127 Trieste, Italy; fabrizio.zanconati@asuits.sanita.fvg.it (F.Z.); G.POZZATO@fmc.units.it (G.P.);
lmurena@units.it (L.M.); fiotti@units.it (N.F.)
7 Department of Clinico-Surgical Sciences, Experimental Surgery Laboratory, University of Pavia and
IRCCS S, Matteo Hospital Pavia, 27100 Pavia, Italy; lauracansolino@libero.it
* Correspondence: ggrassi@units.it
Received: 29 June 2017; Accepted: 16 August 2017; Published: 21 August 2017
Abstract: Because of its high biocompatibility, bio-degradability, low-cost and easy availability,
cellulose finds application in disparate areas of research. Here we focus our attention on the most
recent and attractive potential applications of cellulose in the biomedical field. We first describe
the chemical/structural composition of cellulose fibers, the cellulose sources/features and cellulose
chemical modifications employed to improve its properties. We then move to the description of
cellulose potential applications in biomedicine. In this field, cellulose is most considered in recent
research in the form of nano-sized particle, i.e., nanofiber cellulose (NFC) or cellulose nanocrystal
(CNC). NFC is obtained from cellulose via chemical and mechanical methods. CNC can be obtained
from macroscopic or microscopic forms of cellulose following strong acid hydrolysis. NFC and CNC
are used for several reasons including the mechanical properties, the extended surface area and
the low toxicity. Here we present some potential applications of nano-sized cellulose in the fields
of wound healing, bone-cartilage regeneration, dental application and different human diseases
including cancer. To witness the close proximity of nano-sized cellulose to the practical biomedical
use, examples of recent clinical trials are also reported. Altogether, the described examples strongly
support the enormous application potential of nano-sized cellulose in the biomedical field.
Keywords: cellulose; wound healing; bone-cartilage regeneration; dental application; siRNA;
drug-cell delivery
1. Introduction
The use of low-cost and renewable materials has attracted more and more interest from the
scientific community. Among renewable resources, cellulose represents a very appealing material.
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Cellulose is the most abundant and renewable biopolymer in nature. It is the main constituent
of plant cell walls in wood, cotton, hemp and other plant-based materials and plays an essential
role in maintaining plant structural phase. Cellulose is also synthesized by marine animals such
as tunicates, algae, fungi [1–3] and several bacteria species belonging to the genera of Acetobacter,
Rhizobium, Agrobacterium and Sarcina [4]. Cellulose is a carbohydrate homopolymer consisting of
β-D-glucopyranose units joint together by β-1,4-glycosidic linkage [5]. Cellulose fibrils are highly
insoluble and inelastic but able to provide mechanical support to the tissues where they resides [6].
Since cellulose is of natural origin, the biocompatibility [7] and bio-degradability are other features
scientists are looking for in this amazing material.
Because of the above positive properties, cellulose has found application in different research fields
such as the biomedical, energy, environmental and water related fields [8] . In this review, we focus on
the cellulose employment in the biomedical field. Particularly, we concentrate our attention on the
most recent advances obtained with regard to wound healing (Section 5.1), bone-cartilage regeneration
(Sections 5.2 and 5.3), dental application (Section 5.4), human diseases such as cancer (Section 5.5) and
finally on most recent clinical trials (Section 5.6). The description of cellulose potential application in
the biomedical field is preceded by the presentation of cellulose structure (Section 2), source (Section 3),
and the types/chemical modifications of cellulose used in biomedical studies (Section 4).
2. Chemical and Structural Composition of Cellulose Fibers
Cellulose is a high molecular weight natural homopolymer, composed of α-1,4-linked
anhydro-D-glucose units. The sugar units are linked by combining the H and –OH group together
with the elimination of water. Linking two of these sugars produces a disaccharide called cellobiose
(Figure 1) [9]. The glucose units are in 6-membered rings, called pyranoses. They are joined by
single oxygen atoms (acetal linkages) between the C-1 of one pyranose ring and the C-4 of the next
ring. Since the water molecule is lost due to the reaction of an alcohol and a hemiacetal to form
an acetal, the glucose units in the cellulose polymer are referred to as anhydroglucose units [10].
The cellulose molecule contains three different kinds of anhydroglucose units, the reducing end with a
free hemiacetal (or aldehyde) group at C-1, the nonreducing end with a free hydroxyl at C-4 and the
internal rings joined at C-1 and C-4 (Figure 2) [11].
The stereochemistry at carbons 2, 3, 4 and 5 of the glucose molecule are fixed, but in pyranose
form, the hydroxyl at C-4 can approach the carbonyl at C-1 from either side, resulting in two different
stereo chemistries. If the hydroxyl group at C-1 is on the same side of the ring as the C-6 carbon,
it is said to be in the α configuration. In cellulose, the C-1 is positioned oppositely producing β
configuration [12]. Functional groups of cellulose β configuration are in equatorial positions, making
the cellulose molecular chain to be more or less extended in straight line [10].
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Figure 1. Cellobiose unit (redrawn from [9]). 
In nature, cellulose does not occur as an isolated individual molecule. Although cellulose is 
biologically synthesized as individual molecules, they undergo spinning in a hierarchical order at the 
site of biosynthesis. In the case of primary cell wall of plants, glucose residues are polymerized into 
In nature, cellulose does not occur as an isolated individual molecule. Although cellulose is
biologically synthesized as individual molecules, they undergo spinning in a hierarchical order at the
site of biosynthesis. In the case of primary cell wall of plants, glucose residues are polymerized into
individual chains. Later, 36 chains are assembled together to form a microfibril. During synthesis of
the plant secondary wall, microfibrils often associate further to form bundles (Figure 3). However,
the chain length may varies ranging from as low as 2000 up to 20,000 glucose residues [9].
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3. Sources and Properties of Cellulose 
Cellulose can be obtained from various sources. The conventional and primary source is from 
wood of higher plant. Cellulose also origins from agricultural residues such as palm trunk and empty 
fruit bunch, corncobs, wheat straw, sugarcane bagasse, corn stover, coconut husks, wheat rice and 
empty fruit bunches [14]. In addition to its plant origins, cellulose fibres are also secreted 
extracellularly by certain bacteria belonging to the genera Acetobacter, Agrobacterium, Alcaligenes, 
Pseudomonas, Rhizobium, or Sarcina [15]. 
Plant cellulose (PC) lies in the xylem tissues that are known as wood where cellulosic microfibrils 
are embedded in a matrix of hemicellulose (an amorphous non-cellulosic polysaccharides) and lignin 
[16]. Lignin keeps the water in fibers acting as a stiffener and making the plant stem resistance against 
gravity forces, wind and provides protection against biological attack. Hemicellulose presence is 
believed to serve as compatibilizer between cellulose and lignin [17]. Because of the presence of lignin 
and hemicellulose PC is regarded as less promising for biomedical applications. Indeed, lignin would 
not be biodegradable under the conditions found in the body and the effects of its prolonged 
residence in the body would be very hard to predict. Moreover, the harsh chemicals needed to 
remove lignin and hemicellulose may have deleterious effects in the body due to residual chemicals 
and their byproducts. 
In addition to plant, bacteria also synthesize cellulose (bacterial cellulose BC). BC is chemically 
identical to PC but not in terms of the macromolecular structure and arrangement, hence their 
.
Materials 2017, 10, 977 3 of 31 
 
individual chains. Later, 36 chains are assembled together to form a microfibril. During synthesis of 
the plant secondary wall, microfibrils often associate further to form bundles (Figure 3). However, 
the chain length may varies ranging from as low as 2000 up to 20,000 glucose residues [9]. 
 
Figure 2. Chemical structure of cellulose (adapted from [11], with permission from © 2010 American 
Chemical Society). 
 
Figure 3. Glucose residues polymerized into individual chain and further assemble into microfibrils 
and macrofibrils or bundles (redrawn from [9]). 
In the ordered regions, cellulose chains are tightly packed together in crystallites, which are 
stabilized by a strong and very complex intra- and intermolecular hydrogen-bond network. The 
hydrogen-bonding network and molecular orientation in cellulose can vary widely, which can give 
rise to cellulose polymorphs or allomorphs. Six interconvertible polymorphs of cellulose, namely, I, 
II, IIII, IIIII, IVI, and IVII, have been identified. Meanwhile the amorphous regions are distributed as 
chain dislocations on segments along the elementary fibril where the microfibrils are distorted by 
internal strain in the fiber and proceed to tilt and twist [13]. Native cellulose has been thought to have 
cellulose I shape. 
3. Sources and Properties of Cellulose 
Cellulose can be obtained from various sources. The conventional and primary source is from 
wood of higher plant. Cellulose also origins from agricultural residues such as palm trunk and empty 
fruit bunch, corncobs, wheat straw, sugarcane bagasse, corn stover, coconut husks, wheat rice and 
empty fruit bunches [14]. In addition to its plant origins, cellulose fibres are also secreted 
extracellularly by certain bacteria belonging to the genera Acetobacter, Agrobacterium, Alcaligenes, 
Pseudomonas, Rhizobium, or Sarcina [15]. 
Plant cellulose (PC) lies in the xylem tissues that are known as wood where cellulosic microfibrils 
are embedded in a matrix of hemicellulose (an amorphous non-cellulosic polysaccharides) and lignin 
[16]. Lignin keeps the water in fibers acting as a stiffener and making the plant stem resistance against 
gravity forces, wind and provides protection against biological attack. Hemicellulose presence is 
believed to serve as compatibilizer between cellulose and lignin [17]. Because of the presence of lignin 
and hemicellulose PC is regarded as less promising for biomedical applications. Indeed, lignin would 
not be biodegradable under the conditions found in the body and the effects of its prolonged 
residence in the body would be very hard to predict. Moreover, the harsh chemicals needed to 
remove lignin and hemicellulose may have deleterious effects in the body due to residual chemicals 
and their byproducts. 
In addition to plant, bacteria also synthesize cellulose (bacterial cellulose BC). BC is chemically 
identical to PC but not in terms of the macromolecular structure and arrangement, hence their 
Figure 3. Glucose residues polymerized into individual chain and further assemble into microfibrils
and macrofibril o bundles (redrawn from [9]).
the order d regions, cellulose chains are tightly packed tog ther in crystallites, which are stabilized
by a strong and very complex intra- and intermolecular hydrogen-bond network. The hy rogen-bonding
netw rk and molecular ientation in cellulos c n vary widely, which can give rise to cellulos
polymorphs r all morphs. Six interc nvertible polymorphs of cellulose, namely, I, II, IIII, IIIII, IVI
and IVII, have bee identified. M a while th amorphous regions are distributed as ch in dislocations on
segment along the elementary fibril where the microfibrils are distorted by internal strain n the fiber
a d proceed to til and twist [13]. Native cel ulose has been thought to have cellulos I shape.
3. Sources and Properties of Cellulose
Cellulose can be obtained from various sources. The conventional and primary source is from
wood of higher plant. Cellulose also origins from agricultural residues such as palm trunk and
empty fruit bunch, corncobs, wheat straw, sugarcane bagasse, corn stover, coconut husks, wheat
rice and empty fruit bunches [14]. In addition to its plant origins, cellulose fibres are also secreted
extracellularly by certain bacteria belonging to the genera Acetobacter, Agrobacterium, Alcaligenes,
Pseudomonas, Rhizobium, or Sarcina [15].
Plant cellulose (PC) lies in the xylem tissues that are known as wood where cellulosic microfibrils are
embedded in a matrix of hemicellulose (an amorphous non-cellulosic polysaccharides) and lignin [16].
Lignin keeps the water in fibers acting as a stiffener and making the plant stem resistance against gravity
forces, wind and provides protection against biological attack. Hemicellulose presence is believed to serve
as compatibilizer between cellulose and lignin [17]. Because of the presence of lignin and hemicellulose
PC is regarded as less promising for biomedical applications. Indeed, lignin would not be biodegradable
under the conditions found in the body and the effects of its prolonged residence in the body would be
very hard to predict. Moreover, the harsh chemicals needed to remove lignin and hemicellulose may have
deleterious effects in the body due to residual chemicals and their byproducts.
In addition to plant, bacteria also synthesize cellulose (bacterial cellulose BC). BC is chemically
identical to PC but not in terms of the macromolecular structure and arrangement, hence their
properties are different (Figure 4) [18]. BC has been regarded as “generally recognized as safe”
by the FDA [19]. The safety of BC stems from the fact that it is free of lignin, hemicellulose structures,
does not have any sulfur and it does not need to involve any chemical synthesis and/or treatments.
Moreover, purification methods allow obtaining BC with a content of endotoxin falling within the
acceptable range indicated by FDA for biomedical applications [19].
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BC aggregates to form sub-fibrils, which have the width of approximately 1.5 nm, the thinnest
natural occurring fibres. BC sub-fibrils are then crystallized into bundles and latter into ribbons [4] as
reported in Figure 5. Several researchers had performed and recorded a few dimensions of BC ribbons.
According to Zaar [20] the ribbons were 3–4 nm thick and 70–80 nm long, while Brown et al. [21]
reported dimension of 3.2 × 133 nm, whereas Yamanaka et al. [22] noted 4.1 × 117 nm. Other
researchers showed that these ribbons (sometimes called fibrils) can reach dimension around 10–100 nm
width and 10 µm in length depending on the type of the culture medium and surroundings [6,23–25].
Stabilized by extensive hydrogen bonding, these BC ribbons form a dense reticulated structure. BC
also differs from plant cellulose by having a higher crystallinity [4]. In addition, BC is produced as
a highly hydrated and relatively pure cellulose membrane and therefore no chemical treatments are
needed to remove lignin and hemicelluloses, as is the case for plant cellulose [26,27].
With regard to BC synthesis by bacteria, the most important enzyme is cellulose synthase
while cyclic diguanylmonophosphate (c-di-GMP) acts as the activator to the cellulose synthase.
The production of cellulose from glucose was suggested according to a biochemical pathway by
De Wulf et al. [28]. The two most common carbon sources used in bacterial cellulose production are
glucose and sucrose. However, many other carbon substrates can be used for cellulose production such
as arabitol and mannitol [29,30], glycerol [31] and fructose [32]. In a previous study, Masaoka et al.,
reported that a low concentration of glucose (less then 15 g/L) could produce up to 0.6 g of cellulose
for each gram of glucose per day after 2–4 days of cultivation. For comparison, Oikawa [30] reported
that mannitol produced 0.233 g/g/day of cellulose whereas arabitol produced 0.155 g/g/day of
cellulose [29]. Finally, beside the above carbon sources, Acetobacter can also consume citrate, gluconate,
gluconolactone and lactate as its carbon sources [4].
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4. Isolation and Chemical Modifications of Cellulose
4.1. Nanofibrillar Cellulose (NFC)
As mentioned before, native cellulose fibers are built up by mechanically strong and long thin
filaments. These are also called microfibrils and consist of alternating crystalline and non-crystalline
domains. From microfibrils it is possible to obtain nanofiber cellulose (NFC) which are used in
biomedical applications. Various mechanical shearing methods or a combination of both chemical and
mechanical methods can be used to obtain NFC. For example, Surip et al. [33] had produced NFC of
40–200 nm in diameter from kenaf fiber which was treated with alkali followed by acidic treatment
(HCl) before it was mechanically processed by using pulverisette and cryo-crushing. In general NFC
is a material composed by nanosized cellulose fibrils with a high aspect ratio (length to width ratio).
Fibril widths can be as small as 3–10 nm but typically the size ranges between 20–40 nm with a wide
range of lengths up to several micrometers [34]. Finally, the most interesting NFC material is the one
produced by several bacterial strains which is referred to as BC (see above). BC is a pure cellulose
and therefore no chemical treatments are required to remove lignin and hemicelluloses, as is the case
for PC. For these reasons, BC is often preferred to cellulose obtained from other sources. However,
reports exist suggesting that plant derived cellulose is better since BC may have inconsistent structural
morphology and the encapsulation of substances may be difficult [35].
4.2. Cellulose Nanocrystal (CNC)
When subjected to strong acid hydrolysis, macroscopic or microscopic forms of cellulose undergo
transverse cleavage along the amorphous regions resulting in the production of a rod-like material referred
to as cellulose nanocrystal (CNC) [36]. The typical diameter of CNC is around 2–20 nm with a wide range
of length distribution from 100 to 600 nm [37]. CNC has attracted a spectacular interest in the field of
nanocomposites due to unique properties such as high surface area (and a surface area of several hundred
meter per each gram) [38], low density (estimated to be 1.61 g/cm3) [4], readily available, renewable,
and biodegradable. The impressive mechanical strength with a Young’s modulus around 150 GPa makes
CNC a desirable and highly potential candidate as green reinforcing material for composite [39–41].
Sulfuric and hydrochloric acids have been extensively used for CNC preparation. The use of
the two different acids produces CNC with different properties. If CNC is prepared by hydrolysis in
hydrochloric acid, its ability to disperse in aqueous medium is limited and it tends to flocculate [42].
In contrast, the use of sulfuric acid promotes the dispersion of CNC in water. This may be due
to the reaction on the surface hydroxyl groups of cellulose that yield charged surface of sulphate
esters. However, the introduction of charged sulfate groups compromises the thermo-stability
of the nanocrystals) [43]. Another difference observed between the two acids is the rheological
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behavior. Suspensions obtained from sulfuric acid hydrolysis have shown no time-dependent viscosity.
In contrast, the hydrochloric acid-treated suspension showed a thixotropic (time-dependent shear
thinning) property behavior at concentrations above 0.5% (w/v) and antithixotropic behavior at
concentrations below 0.3% [42].
The acid concentration, hydrolysis time and temperature variation produce CNC with different
morphology and characteristics as summarized in Table 1. CNC has the potential to be used as
reinforcing materials in structural composites industry to fabricate building boards. However several
attempts had been made to introduce CNC in the biomedical field (see Section 6) for example to
improve the mechanical properties of hydrogel used for drug delivery [44,45].
Table 1. Typical geometrical characteristics for cellulose nanocrystal (CNC) originating from different
cellulose sources and obtained via different procedures.
Sources of Cellulose Hydrolysis Procedure Nanocellulose Dimension References
Rice husk fibers
10.0 mol L−1 of sulphuric acid
(pre-heated) at 50 ◦C for 40 min
under continuous stirring.
60 wt % H2SO4 solution at 45 ◦C
for 45 min.
TEM micrograph Diameter and
aspect ratio in the range of
15–20 nm and 10–15 respectively
AFM micrograpgh Average
diameter 12.4 ± 4.6 nm.
Johari et al. [44]
Ludueña et al. [46]
Pandanus tectorius 60 wt % H2SO4 solution at 45
◦C
for 45 min.
TEM micrograph Length from 50 to
400 nm, with an average value
around 200 nm.
Diameter was in the range 5–25 nm.
Sheltami et al. [47]
Coconut husk fiber
64%brt H2SO4 solution at 45 ◦C
for 30 min under
continuous stirring.
TEM micrograph Average length
172.34 ± 8.4 nm.
Average diameter 13.7 ± 6.2.
Aspect ratio 14.23 ± 8 nm.
Ahmad and Ahmad [48]
kenaf bast fibers 65 wt % H2SO4 120 min
TEM micrograph Average length
124.3 ± 45.3 Average diameter
11.3 ± 2.6 (nm)
Kargarzade et al. [49]
waste sugarcane bagasse
60% (w/v) sulfuric acid (fiber to
liquor ratio of 1:20) for 5 h at 50 ◦C
under strong agitation.
TEM micrograph Length and
diameter: 170 nm × 35 nm.
Mandal and
Chakrabart [50]
Sisal fibers
60 wt % sulphuric acid solution at
45 ◦C, 30 min under
continuous agitation.
AFM micrographs Diameter,
average size of 30.9 ± 12.5 nm Mora´n et al. [51]
47 wt % sulfuric acid with fiber to
solution ratio of 1:20 by refluxing
for 3 h at 60 ◦C under
strong agitation.
TEM micrograph
Length of 200–350 nm.
Diameter of 40–50 nm
Reddy and Rhim [52]
Oil Palm Empty Fruit
Bunch Fiber
64 wt % sulfuric acid solution
under strong agitation at
45 ◦C for 45 min
TEM micrograph
Diameter range of 4–15 nm Lani et al. [53]
banana pseudostems
fibers (Musa sp.)
50.0 mL of 64% (w/w) sulfuric
acid at 45 ◦C and stirred
for 70 min
TEM micrograph
Mean length (L) of the
nanostructures was 135.0 ± 12 nm,
the mean 269 diameter (D) was
7.2 ± 1.9 nm, and the mean aspect
ratio (L/D) was 21.2 ± 2.8
Pereira et al. [54]
Raw cotton linter
Sulfuric acid (60%, w/w) with a
Teflon© bar dispersing element,
at 45 ◦C, for 60 min.
TEM micrograph
177 nm long (ranging from 161 to
193), 12 nm wide (ranging from
10 to 13), and have an aspect ratio
(L/D) of 19 (ranging from 20 to 24).
Morais et al. [55]
Ushar (Calotropis procera)
seed fiber
64 wt % sulfuric acid solution with
fiber to acid ratio of 1:20 at 50 ◦C
for 75 min with strong agitation
Diameter of 14–24 nm and length of
140–260 nm. Oun and Rhim [56]
Micro crystalline
cellulose
Enzymatic degradation
(Clostridium and
Coccobacillus–cellulase
producing organisms)
AFM micrograph smaller particles
43 ± 13 nm bigger particles
119 ± 9 nm
Satyamurth and
Vigneshwaran [57]
Materials 2017, 10, 977 7 of 31
4.3. Microcrystalline Cellulose (MCC)
The strong hydrogen bonding between individual CNC promotes re-aggregation during
spray-drying procedures [58]. This event leads to the formation of another cellulose structure called
microcrystalline cellulose (MCC). The length dimension of MCC is generally greater than 1 µm.
MCC is stable, chemically inactive, and physiologically inert with attractive binding properties [11].
Commercially available MCC is used: (1) as a rheology control agent; (2) as a binder in the
pharmaceutical industry [59]; (3) as a tablet binder and in food applications and (4) as a texturizing
agent and fat replacer [11].
4.4. Chemical Modification of Nano Cellulose
Nano cellulose chemical modifications, which include esterification, cationization, carboxylation,
silylation and polymer grafting [8], can produce derivatives with wider applications. During
modification, certain functional groups are introduced with the aim to: (1) increase the amount of stable
positive or negative charges for better dispersion; (2) improve compatibility, especially when used in
conjunction with nonpolar or hydrophobic matrices in nanocomposites [11]. Among most common
chemical modifications there are acetylation and carboxy-methylation as below detailed. Cellulose
acetate (CA) is produced by using acetic anhydride in acetic acid [60–62]. Carboxymethyl cellulose
(CMC) is produced when the hydroxyl groups is substituted with the carboxymethyl group [63]. CMC
is the most important water-soluble cellulose derivative, which finds many applications in the food
industry, in cosmetics, in pharmaceuticals and many more [64].
Whereas the above reported chemical modifications can improve nanocellulose properties in
relation to the specific application, there are some points to be considered with regard to their
biomedical use. First, derivatization can make the produced material more expensive. Second, chemical
modifications can make cellulose “less natural” and therefore less likely to be accepted by regulatory
agencies. With regard to this last aspect, it has to be pointed out that limited data regarding the toxic
potential of such modifications are available. A recent work [65] elegantly explored in the embryonic
zebrafish animal model, the potential toxicity of cellulose modifications. Compared to previous tests
limited to the analysis of the effects at the cytological level, this work explores the effects on a more
complex and informative model of developing vertebrate. Among others, the authors evaluated
the effects of the addition of carboxyl, ethoxyethanol, ethylenediamine, hexamethylenediamine and
sulfur groups to cellulose. The results indicated that the chemical modification considered induced
relatively low incidences of mortality or any other developmental impairment when the embryos were
exposed to doses below the relatively high concentration of 1000 mg/L for 5 days. These data seem
to support no significant toxicity in the animal model considered, at least with regard to an acute
exposure. Obviously, the effects of longer time exposure need to be further investigated. Despite this,
the substantial lack of major adverse effects in an animal model and the known biocompatibility of
nanocellulose [7] makes this material with and without chemical modification attractive form many
biomedical applications.
5. Biomedical Applications
5.1. Wound Healing
In the process of wound healing, a number of pathophysiological events such as tissue
regeneration, repair and reconstruction take place [66]. Another relevant biological event is represented
by angiogenesis, a process involving the growth of certain cell type named endothelial cells [67].
Angiogenesis is a pivotal determinant in wound repair as newly generated blood vessels allow the
transport of oxygen and nutrients to cells at the site of wound [68] (Figure 6). Among wounds, those
caused by thermal sources represent a critical problem for clinicians especially due to the high risk
of bacterial infections. Infections can delay wound healing and can be responsible for up to 75%
morbidity in burn patients [69]. Additionally, extended skin burn wounds can lead to excessive fluid
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loss and possibly to patient death. Thus, in burn patients, proper wound healing is crucial for survival.
Critical is also the healing of wound in patients undergoing oncological treatments. In these subjects,
the oncological treatments can impair tissue vitality rendering proper wound healing problematic.
Finally, wound healing can be also challenging in patients with comorbidities, which can negatively
affect the healing process.
Despite current advances in wound treatment, optimal approaches to promote would healing and
contain bacterial infection are lacking. In this regard, the use of cellulose-based material is emerging as
an attractive option.
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Figure 6. (A) The wound causes the formation of the clot (dark red area) and the recruitment of
macrophages (blue) and neutrophils (round blue); (B) Fibroblasts (white) are also recruited to the
ound site to fill it via collagen production (light brown); (C) Collagen and fibroblats rebuilt the tissue
ind cing endothelial cells proliferation and vessel generation; (D) Skin stem cells generate mature skin
cells obtain the w und closing.
Nano-Sized Cellulose-Based aterial in ound Healing
In general, the cellulose containing materials here described (Table 2) are used with the intent not
to persist in the biological environment for very long time, rather to be subsequently degraded after
having completed their functions.
CNC was used to generate a delivery composite containing poly(lactic-co-glycolic acid) (PLGA).
This, in turn, was loaded with pre-assembled polyethylenimine (PEI) and carboxymethyl chitosan
(C CS) (PLGA/CNC/CMCS) containing curcumin (Cur) and the DNA encoding for angiogenin
(ANG) [70] (see also Figure 7). CNC, obtained by acid hydrolysis from MCC, was used to confer to the
delivery complex improved mechanical properties. PLGA is a copolymer often used in therapeutic
devices due to its biodegradability and biocompatibility [71]. PEI, a polymer with repeating unit
composed of the amine group and two carbon aliphatic CH2-CH2 spacer, is often used as bio-delivery
agent [71]. CMCS is a derivative of chitosan, a high molecular weight polysaccharide of natural
origin often emplyed as delivery material [72]. Cur has antioxidant, antitumor, anti-inflammatory
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and anti-bacterial properties, which can be used to improve wound healing. ANG is an angiogenic
factor that can stimulate blood vessel formation thus promoting wound repair. With regard to
the delivery properties of the PLGA/CNC/CMCS/Cur/pDNA-ANG compound in vitro, Cur was
released with an initial burst (24 h) followed by a slower rate that lasted up to 144 h. DNA
coding for ANG was released at a rate of nearly 50% over the first 3 days and more than 90% was
released over the following 21 days. Together these data support the prolonged and controlled
release of the two therapeutic compounds considered, i.e., Cur and ANG. In the endothelial human
cells HUVEC, PLGA/CNC/CMCS/Cur/pDNA-ANG nanoparticles induced the increase of ANG
expression of about 3 times compared to empty nanoparticles. This was due to the delivery of the
DNA encoding for ANG, which promoted ANG expression. Notably no significant cell toxicity
was induced by the nanoparticles in vitro. In a rat model of skin full-thickness burn, compared to
control, PLGA/CNC/CMCS/Cur/pDNA-ANG treated animals always had a significantly higher
expression of ANG. The increased ANG expression was paralleled by an improved density of mature
vessels compared to empty nanoparticles. Even more importantly, PLGA/CNC/Cur/pDNA-ANG
treated animals had significantly improved wound healing 14, 21, and 28 days post nanoparticles
administration compared to animals treated by empty nanoparticles.
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Figure 7. Schematic illustration of reparation of PEI-CMCS/pDNA complex nanoparticles, and assembly
with Cur, CNC and PLGA; electrospinning wa used to deliver the composite nan fiber to rat wounded
skin. Redrawn for ref [70]. ANG = Angiogenin; CMCS = carboxymethyl chitosan; Cur = curcumin;
pDNA = plasmid DNA; PEI = polyethyleneimine; PLGA = poly(D,L-lactic-co-glycolic acid).
In a variation of the above experiment, Cur was loaded into gelatin microspheres (GMs) and then
mixed with a porous collagen (Coll) containing chemically synthesized CNC to form the composite
s affold (Cur/GMs/ ol-CNCs scaffold) [73]. CNC was used to improve the echanical properties
of the scaffold and bec use of its lack of c ll toxicity. In vitro, Cur release from Cur/GMs/Col-CNCs
scaffold reached 100% ter 240; much shorter was in contrast the release from Cur/Col-CNCs
(25 h) and Cur/GMs (130 h). This indicates the prolong d and c ntrolled delivery m iat d by
the Cur/GMs/Col-CNCs scaff ld. Moreover, the in vitro antimicrobial activity (against Escherichia coli,
Stap ylo occus aureus nd Pseudomonas aeruginosa) was re arkable for the Cur/GMs/Col-CNCs scaffold.
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The effectiveness of Cur/GMs/Col-CNCs scaffold was then tested in a wound-infection model based
on full-thickness burn in rats, in which the dorsal skin was artificially burned and infected with
Pseudomonas aeruginosa. The Cur/GMs/Coll-CNCs group exhibited higher epithelializing rates than
the sterile gauze group, most likely because of the extended release of Cur. Moreover, the Cur/GMs/
Coll-CNCs group had the smallest skin defect and the newly generated skin was similar to the
surrounding skin, accompanied with the growth of hair. This is probably due to the excellent oxygen
permeability, controlled evaporative water loss, promotion of fluid drainage and maintenance of a
humid healing environment compared to the sterile gauze group.
NFC of bacterial origin was used to prepare a sustained delivery matrix for the antiseptic drug
octenidine [74]. The choice of NFC was based on its high mechanical and thermal stability as well as
softness. Moreover, it was chosen because of its extended surface area that can hold a large amount of
drug molecules. Octenidine is used for the local treatment of wounds to down regulate the development
of bacterial infection. A prolonged delivery is important to control bacterial infection for the time required
to the wound to heal. To obtain a prolonged delivery, NFC was combined with Poloxamers, amphiphilic
surfactants composed of polyethylene oxide (PEO)/polypropylene oxide (PPO) arranged in a triblock
structure as PEOx-PPOy-PEOx [75]. Polaxamers form micelles with a core of hydrophobic PPO blocks and
a shell of strongly hydrophilic PEO in an aqueous environment and thus can be loaded by the hydrophilic
drug octenidine. The presence of Poloxamers and NFC allowed delayed and prolonged delivery of
octenidine up to one week in vitro. Moreover, the anti-bacterial activity of octenidine was maintained
against the bacterial strains Staphylococcus aureus and Pseudomonas aeruginosa. Importantly, no significant
in vitro cell toxicity was observed for the CNF-Polaxamers delivery matrix.
NFC of bacterial origin was also used to deliver another antimicrobial compound, i.e., zinc
oxide (ZnO) [76]. Bacterial NFC was employed due to the high biocompatibility, hydrophilicity and
nontoxicity, all features that in the opinion of the authors make this material ideal for wound care. ZnO
is an inorganic compound with anti-bacterial properties. Whereas NFC alone did not display significant
antimicrobial activity, the addition of ZnO conferred the ability to effectively down regulate the growth
of different bacterial strains including Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.
In vivo, in a skin burn mice model, NFC -ZnO showed enhanced wound healing and tissue regeneration
activity as compared to NFC alone. Interestingly, histologic analysis revealed that in NFC-ZnO treated
tissues the whole surface of wound bed was covered with regenerated epithelium. Moreover, new hair
follicles were visible near to the wound area. As hair follicles are a reservoir of epithelial stem cells,
their presence supports the ongoing regenerative process. Finally, new blood vessels were observed
deeper in the wound tissue, further confirming the occurrence of the reparative process.
In addition to minimize the risk of infection, wound healing can be improved via an accelerated
reconstitution of the damaged tissue. This is particularly true for the surgery wounds. To promote
tissue regeneration and thus wound healing, the use of human adipose mesenchymal stem cells (hASC)
is considered an effective strategy [77]. However, the efficacy of any stem cell therapy depends on the
ability to properly deliver and retain cells at the target area. The simple local injection of stem cells
commonly results in low cell retention as most of the cells circulate via bloodstream [78]. In addition,
the cell delivery/carrier material should not interfere with stem cell biology. In a recent work [79], plant
NFC was used to prepare threads containing hASC to suture wounds. NFC was used because of its
biocompatibility and mechanical properties. To further improve the mechanical strength, NFC threads
have been reinforced by glutaraldehyde cross-links, which created bridges within different threads
(NFC-X) (see also Figure 8). Notably, improved mechanical strength was maintained under the wet
cell culture or surgery conditions, a challenging feature for cellulosic materials. Notably, the generated
treads resulted to be mechanically robust enough to pass through different tissues (muscle, fat and
skin). Moreover, hASC could properly adhere, migrate and proliferate on the NFC-X. Importantly,
NFC-X threads maintained the hASC undifferentiated profile and functionality in an ex vivo suturing
assay. This opens the possibility that in vivo hASC may have the ability to engraft the sutured tissue
accelerating wound healing.
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Figure 8. Schematic preparation of nanofibrillar cellulose with glutaraldehyde cross-links (NFC-X)
threads and their cross-linking with glutaraldehyde for NFC-X threads. Following preparation, NFC-X
threads were loaded with human adipose mesenchymal stem cells (hASC); cells could properly, adhere,
migrate and proliferate on the NFC-X. Redrawn from ref [79].
Table 2. Summary of the nano cellulose-based materials tested in wound healing.
Type of Cell terialealesed itro Test In Vivo Tests Molecu ar Effects Referenc s
PLGA/CNC/CMCS Cur and ANG HUVEC cells Skin full-thicknessburn Rat model
Increase of ANG
expression, improving
wound healing
Mo et al. [70]
Cur/GMs/Col-CNC
scaffold Curcumin
Escherichia coli,
Staphylococcus
aureus and
Pseudomonas
aeruginosa
Skin full-thickness burn
rat model in which the
dorsal skin was
artificially burned and
infected with
Pseudomonas aeruginosa
in vitro:
antimicrobial activity;
in vivo: exhibited higher
epithelializing rates
Guo et al. [73]
NFC-
PEOx-PPOy-PEOx Octenidine
Vertical diffusion
cells and
antimicrobial tests
Down regulation of
bacterial infection Alkhatib et al. [74]
NFC Zinc oxide(ZnO) Skin burn mice model
Enhanced wound
healing and tissue
regeneration act vity
Khalid et al. [76]
NFC-X hASC cells The cells adhere, migrateand proliferate properly Mertaniemi et al [79]
PLGA/CNC/CMCS = poly(lactic-co-glycolic acid)/cellulose nanocrystals/carboxymethyl chitosan; Cur = curcumin;
ANG = angiogenin; Cur/GMs/Col-CNC = Curcumin/gelatin microspheres/collagen/cellulose nanocrystal;
NFC- PEOx-PPOy-PEOx = nanofibrillar bacterial cellulose/polyethylene oxide (PEO)/polypropylene oxide (PPO)
arranged in a triblock structure; NFC-X = nanofibrillar cellulose with glutaraldehyde cross-links; hASC = human
adipose mesenchymal stem cells.
5.2. Bone Regeneration
The increase in the life expectancy together with the high incidence of diseases that cause bone
loss, such as infections, tumors and trauma, makes the optimization of bone grafts technology very
relevant. This necessity is particularly true in elderly people where the bone turnover is significantly
decreased compared to young people.
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Ideally, the grafted material should: (1) promote the differentiation and growth of the main
cellular component in the bone, i.e., osteoblasts; (2) guiding bone growth to the desired areas; (3) favor
the integration of the new growing bone into the surrounding bone; (4) favor the deposition of calcium
phosphate crystals, pivotal components of the bone; (5) favor vessel formation to nourish novel
osteogenic cells (Figure 9).
As hydroxyapatite (Ha) is the main calcium phosphate phase constituent of natural bones,
in principle it represents the ideal grafting material. However, synthetic Ha presents some drawbacks
associated with its mechanical and chemical stability [80]. Among other materials, nanocellulose is
emerging as an attracting solution for the development of novel and effective bone grafting techniques.
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s pointed out in the previous section, also in the bone regeneration field, the nano-sized cellulose
used is intended to be degraded over time eventually disappearing (Table 3). Moreover, mostly
chemically modified nano-sized cellulose materials have been employed in most recent works as
below detailed.
C C [81] has been used in combination with silk fibroin (SF) to generate a bone-grafting scaffold.
SF is a protein contained in the silk produced by the silkworm Bombyx mori. Fibroin is a biopolymer
with tunable mechanical properties, a fact that makes it an important scaffold material for hard tissue
engineering applications. The bone grafting material produced [81] combines the properties of silk
fibroin and CMC. In particular, while SF has high mechanical strength and bio-compatibility, CMC, due
to the presence of carboxymethyl groups, has hydrophilicity and the ability to fix Ca++ via chelation.
The Ca++ fixing ability favors the homogeneous deposition and nucleation of the calcium/phosphate
(Ca/P) crystals on the grafting matrix (see also Figure 10). The SF/CMC scaffold was loaded with
human mesenchymal stem cells (hMSCs) to verify the ability to allow differentiation towards the
osteogenic lineage. The combined SF/CMC material showed excellent physicochemical features
together with the ability to allow the uniform deposition and nucleation of Ca/P over the surface of the
scaffold. Moreover, the SF/CMC scaffold displayed improved osteoblastic differentiation of hMSCs
compared to the pure silk fibroin and gelatin matrix used as controls. Enhanced hMSCs differentiation
was also proven demonstrating the improved expression of the osteoblastic differentiation markers
alkaline phosphatase and RUNX2, compared to gelatin. Together the above data indicate the great
potential of the SF/CMC scaffold for bone regeneration.
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itionally, no details about cellulose structure (CNC, NFC) have been provided. The morphological
evaluation of the fibers constituting the scaffold revealed that the average fiber diameter was dependent
on the presence of nano-Ha. In particular, the diameter increased with the increase of nano-Ha amount
in the scaffold. Notably, the diameter range fall within the diameter distribution of natural extra-cellular
matrix (ECM) fibers (50–500 nm), thus proving the similarity with the physiological ECM. With regard
to the mechanical properties of the scaffold, they were also influenced by the amount of nano-Ha.
In particular, at low nano-Ha concentration (below 5%) the strength was maximal and progressively
declined increasing nano-Ha concentration (10%). This behavior was attributed to the fact that at high
nano-Ha concentration (10%), the formation of a large number of nano-Ha agglomerates occurred.
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These agglomerates were considered responsible for the formation of “defects” in the fiber, which
impaired fiber strength. Nano-Ha also improved scaffold thermal stability most likely because nano-Ha
served as heat isolator. Finally, scaffold toxicity was tested in primary human dental follicle cells
(HDFCs). Whereas not specified in the work, these cells were probably used are they are considered
progenitor cells able to differentiate towards the osteogenic lineage [85]. The ability of HDFCs to
adhere and proliferate on the scaffold was directly proportional to the nano-Ha percent. In particular,
using 3% nano-Ha, cells were viable but did not well spread; cell proliferation obviously increased
using nano-Ha at 5% and it further progressed with the increase of nano-Ha content, reaching the
optimum at 10% when cells reached confluence on the scaffold. This indicates that nano-Ha positively
affects cell behavior on the scaffold. The fact that at 10% nano-Ha cell compatibility is maximal but the
mechanical properties are not, suggests that the amount of 5% nano-Ha may not be exceeded in the
preparation of scaffold to be tested in more complex animal model of bone regeneration.
CA has been combined with pullulan (P) to prepare a 3D bone grafting scaffold [86]. P is
a natural linear polymer composed of glucose residues polymerized into repeating malto-triose
units [72], with the ability to promote osteogenic differentiation in vitro [87]. Moreover, P provides
3-dimensionality to the scaffold, a required property for bone scaffolding. CA has been chosen because
of the excellent mechanical properties that can confer to the scaffold the necessary strength, one of the
main properties of natural bone tissue. Moreover, the physical properties of CA well mimic those of
bone microenvironment [88] thus supporting osteoblast growth in vitro and bone formation. Finally,
following scaffold degradation, CA can be easily eliminated by the kidney. Optimal ratio (%) P/CA
was found to be 50/50. At this ratio, the scaffold consisted of more homogeneous fiber size and
morphology compared to different ratios; these features make the 50/50 ratio suited to host osteogenic
cells. The scaffold was further reinforced by the crosslinking with trisodium trimetaphosphate.
Moreover, the crosslinking made the surface of the scaffold fibers more stable and thus more suited
for mineral deposition. With regard to the porosity, the scaffold had pores within 100 and 400 µm,
thus in line with the porosity necessary for bone formation. The presence of the large pores allows the
formation of new bone and capillaries necessary for the successful diffusion of nutrients and oxygen
within scaffold. Experiments conducted in vitro in the human Osteogenic Sarcoma Cell Line (Saos-2)
confirmed these predictions. Saos-2 cells proliferated up to day 7 after seeding in the scaffold. Notably,
proliferation was not limited to the scaffold surface, it occurred also at 210 µm from the surface, most
likely because of the large porosity of the scaffold that enabled nutrient/oxygen transfer and thus
cell penetration. At day 14, cells became spread and stretched from a fiber to another, exhibiting
filopodia-like features among fibers thus suggesting a certain degree of osteogenic differentiation.
Differentiation was confirmed by evaluating the levels of Alkaline Phosphatase (ALP), a known
marker of osteogenic differentiation. Notably, ALP level was three times higher than that measured
for the same cell line seeded onto a common polystyrene surface. The author speculated that such
increase might be due to the 3-dimensional fibrous network that better mimics the structure of the
ECM. Together the above data suggest that the crosslinked scaffold has the potential to effectively
allowing bone regeneration, a feature that however needs to be confirmed in animal models.
Table 3. Summary of the nano cellulose-based materials tested in bone regeneration.
Type of
Cellulose
Material
Realesed In Vitro Tests In Vivo Tests Molecular Effects References
SF/CMC hMSCs
Uniform deposition and
nucleation of Ca/P over the
surface of the scaffold. The
SF/CMC improved osteoblastic
differentiation of hMSCs
Singh et al. [81]
Zr-CS-CMC Cefazolin Murine OB-6cell line
Promotion of osteogenic
cell proliferation Gaire et al. [82]
Cotton
cellulose Nano-Ha HDFCs
Improved HDFCs adherence and
proliferation on the scaffold Ao et al. [84]
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Table 3. Cont.
Type of
Cellulose
Material
Realesed In Vitro Tests In Vivo Tests Molecular Effects References
CA-P-STMP Saos-2 Formation of newbone and capillaries Atila et al. [86]
HPMC-CaP Calcium PDECs Rat bonedefect model
In vitro: promotion of the VEGF
expression (vasculogenesis);
in vivo: increased bone
regeneration (osteogenesis) and
vessels density
Oliveira et al. [89]
SF/CMC = silk fibroin/Carboxymethylcellulose; hMSCs = human mesenchymal stem cells; Zr-CS-CMC =
Zirconium-chitosan- Carboxymethylcellulose; Zr-CS-CMC-P1 = Zirconium-chitosan- Carboxymethylcellulose prepared
1; Zr-CS-CMC-P2 = Zirconium-chitosan- Carboxymethylcellulose prepared 2; nano-Ha = nano-hydroxyapatite;
HDFCs = primary human dental follicle cells; CA-P-STMP = Cellulose acetate- Pullulan- trisodium trimetaphosphate;
Saos-2 = human Osteogenic Sarcoma Cell Line; HPMC-CaP = Hydroxypropyl)methyl cellulose-calcium phosphate;
PDECs = human progenitor-derived endothelial cells.
(Hydroxypropyl)methyl cellulose (HPMC) in the form of gel has been used to deliver calcium
(Ca) in the form of Ca phosphate (CaP) glass-ceramic particles into the bone [89]. HPMC has been
undertaken as it exhibits suitable biological characteristics and it has already been successfully used for
the delivery of CaP ceramics [90]. Calcium release has the ability to promote vascularization [91] when
delivered in a controlled fashion. Indeed, Ca can induce the migration, maturation and organization of
endothelial progenitors [92]. Improved vascularization is of particular relevance for bone regeneration.
This aspect is of great relevance in the case of large bone defects, where oxygen may not reach
osteogenic cells far from the supplying blood vessels; indeed, passive oxygen diffusion is limited to
about 150 and 200 nm [93]. The injectable hydrogel HPMC-CaP was first tested in cultured human
progenitor-derived endothelial cells (PDECs). In this model, HPMC-CaP did not show any significant
toxicity and promoted the expression of vascular endothelial growth factor (VEGF), a signal protein
able to stimulate vasculogenesis and angiogenesis. In vivo, HPMC-CaP was tested in a rat bone defect
model. In particular, 4 mm diameter and 6 mm depth holes were created in both left and right femoral
condyles of rats. Created holes were then filled with HPMC-CaP and bone regeneration was evaluated
at 3 and 6 weeks post-implantation. Compared to HPMC alone, HPMC-CaP showed increased bone
regeneration as evaluated by histology and micro CT. Notably, a significant increase in vessel density
was observed in HPMC-CaP compared to HPMC treated animals. Together, the presented data indicate
that HPMC-CaP can promote both osteogenesis and vasculogenesis thus representing an attracting
material for future studies in the field of bone regeneration.
5.3. Cartilage Regeneration
Once degenerated, wounded or affected by genetic defects, cartilage has limited ability to heal
and/or regenerate, because it is an avascular tissue. Unfortunately, current reconstructive options for
its repair or replacement are limited. A recent novel option for cartilage replacement is represented by
the bioprinting technology. This technique can generate 3D tissue via the layer-by-layer deposition of
a scaffold structure containing the appropriate cell type. A critical aspect in the generation of printable
structures is represented by use of appropriate bioink that should have appropriate viscoelastic
properties required for printing fidelity and long term structural stability. As an alternative to bioink,
there is the possibility to generate multiple layer scaffolds.
Nano-Sized Cellulose-Based Material in Cartilage Regeneration
A bioink based on NFC and alginate (A) has been used to perform the bioprinting technology [94].
Alginates, a family of unbranched polysaccharides isolated from brown seaweeds [95], are composed
of 1-4-linked β-D-mannuronic acid (M) and alpha-L-guluronic acid (G) arranged in a block-wise pattern.
In the presence of Ca, the different chains of alginates crosslink each other giving origin to strong and
permanent structures. Thus, the generated bioink combines the shear thinning properties of NFC with the
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cross-linking ability of A. In particular, a bioink containing 80/20 (w/w) of NFC and A, has the appropriate
features in term of rheology, compression and shape deformation. The NCF/A bionk was embedded with
human bone marrow–derived stem cells (hBMSCs) and human nasal chondrocytes (hNC) [96]. hBMSCs
and hNC were used together as their combination enhances chondrogenesis [97]. To evaluate neocartilage
formation and the stability of the bioprinted constructs in vivo, the NCF/A loaded by hBMSCs/hNC
was implanted subcutaneously on the back of 6-week-old nude female mice. Wounds were then sutured
and covered with a sterile wound tape. After 60 days, the formed tissue had all the qualitative features
of proper cartilage; moreover, the formation of chondrocyte cell clusters clearly indicated the ability of
embedded cells to proliferate. Notably, cell clusters contained human chromosomes proving their human
origin. Together, these data indicate the feasibility of cartilage synthesis in constructs with high fidelity and
appropriate mechanical and biological properties. Finally, the authors affirm that occurrence of a good
host tissue integration in vivo, thus suggesting the long term permanence of the bioink.
An alternative to the use of bioink for cartilage generation is the preparation of layered scaffolds.
In this regard, bacterial NFC has been used to prepare a bilayer scaffold composed of a dense
layer joined with a composite layer [98]. NFC was used as it is composed by highly hydrated
nanofibrils ranging from 70 to 140 nm in width that resemble the structure of collagen fibrils found in
extracellular matrix of several tissues. Moreover, NFC has the tensile strength required for the specific
application. The dense layer, containing NFC at 17%, was generated by compression; the porous
layer containing NFC and A, was obtained by a freeze-drying process. To tightly fixing the two
layers, the cellulose solvent system “ionic liquid EMIMAc”, was used. The composite layer was
generated with macro porous. Macro porosity is necessary to support cell ingrowth and neo-cartilage
formation. Indeed, NFC tend to be a too dense network which obstacles cell penetration and homing.
The macro porous layer of the scaffold was then loaded with human NC and cultured in vitro for
up to 6 weeks. Following this examination time, the adhesion between the two layers remained
good and the size/shape of the scaffold were maintained. Moreover, the porous layer supported
NC growth also facilitating NC homogeneous distribution. Importantly, NC were able to produce
and accumulate cartilage-specific ECM components in the scaffolds. This observation, together with
the upregulation of the expression of chondrogenic markers, witnesses the suitability of the scaffold
to promote chondrogenesis. Based on these promising in vitro results, the scaffold was implanted
subcutaneously in nude mice. In addition to NC, the scaffold was loaded also with bone marrow
mononuclear cells (MNC), which are known to improve cellular grafting [97]. As control, the scaffold
without cells was implanted. Eight weeks post-implantation, a thin fibrous capsule surrounded the
MNC/NC-scaffold and the cell-free scaffolds. This was considered a normal non-pathological foreign
body reaction. The shape and size of the scaffold remained stable and no delamination between the
two layers was observed. The scaffold seeded with MNC and NC had a macroscopically cartilage-like
appearance. Notably, the MNC/NC-scaffold was stiffer and more stable, compared to the cell free
scaffold. Together these observations indicate the development of a mechanically stable scaffold able
to maintain a long-term structural integrity. In conclusion, the data described strongly support the
suitability of the use of NFC to generate scaffold for cartilage (re)-generation (Table 4).
Table 4. Summary of the nano cellulose-based materials tested in cartilage regeneration.
Type of
Cellulose
Material
Realesed In Vitro Tests In Vivo Tests Molecular Effects References
NFC/A hBMSCs andhNC cells
6-weeks-old
nude female mice
Cartilage reconstruction and
chondrocytes proliferation Moller et al. [96]
Bacterial NFC
bilayer
hNC (in vitro)
hNC and MNC
(in vivo)
NC cell culture with
BCN-bilayer Nude mice Chondrogenesis promotion Martinez et al. [98]
NFC/A = nanofibrillated cellulose/alginate; hBMSCs = human bone marrow–derived stem cells; hNC = human
nasal chondrocytes; MNC = bone marrow mononuclear cells.
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5.4. Dental Applications
In contrast to the wound healing and bone regeneration fields, the cellulose containing materials
used in most dental applications have to persist as much as possible at the application site (Table 5).
For the strong mechanical properties, nano cellulose has been employed as filler in many dental
materials and composites. Glass ionomer cement (GIC) is frequently used in restorative dentistry and its
properties have been constantly improved because of its significant flexibility in clinical applications.
Even though GIC cement has been indicated by international bodies as the definitive restorative material,
scientific investigations are still evolving to improve its wear resistance, compressive and diametric
tensile strength. New GIC formulations are being developed to make use of NFC as a reinforcing agent in
dental restorative material. Recently, Silva et al. [99] modified conventional GIC by NFC from eucalyptus
pulp. The mean values of the length (L) and diameter (D) of the isolated NFC were determined to
be 145 ± 25 nm and 6 ± 1.5 nm, respectively, with an aspect ratio (L/D) of 24. The surface of the
GIC-NFC 0.4% (G04) showed the formation of a network formed by long fibers with uniform width and
random distribution within the matrix. Moreover, it was also found that the addition of NFC increased
substantially all the mechanical properties of the generated material. The compressive strength and
the diametric tensile strength, for example, increased from 49.15 MPa and 28.27 MPa to 103.22 and
43.16 MPa, respectively. Additionally, the elastic modulus increased from 512.61 MPa to 1337.75 MPa.
Reinforcing fibers were also introduced to the family of denture based materials namely
poly(methyl methacrylate) (PMMA), in order to fulfill their requirement of higher mechanical
properties against occlusal overload. Among the wide varieties of reinforcing agents used, glass
fibers [100,101] and several kinds of polymeric fibers for example ultra-high molecular weight
polyethylene fiber (UHMWPE) [102] were employed. Preliminary studies investigating the potential of
ramie fiber as reinforcing agent for denture based resin has been carried out. Ramie, known as “china
grass” and referred to as the best fibers, are extracted from the phloem tissue of the plant. Although the
cellulose fibers were not in the nano-sized scale, the addition of natural fibers was found to improve
the mechanical properties. In general, this modified denture composite had higher flexural modulus
than neat resin but the flexural strength declined due to the weak interfacial adhesion [103]. In this
case, the incorporation of NFC will probably improve the interfacial bonding between the fibers and
the surrounding matrices.
Aside from prosthesis, NFC can be also incorporated in scaffold materials for various dental
procedures. Regenerative dental treatment refers to the restoration of supporting tissues of the teeth
such as bone, cementum and periodontal ligament to their original healthy levels [104]. Bone grafts
are applied with the use of barrier membranes that offer better protection and containment of the bone
substitute inside the defect. There are two types of membrane: (1) resorbable such as collagen and
polylactic acid; (2) non-resorbable membrane materials such as ethyl cellulose. Barrier materials in
the form of semipermeable membranes are placed between the mucoperiosteal flap and the bone and
tooth surfaces during surgery [105]. These barrier membranes can make it possible to prevent the
fast-growing gum tissue from getting into the regenerative site, a fact that might interfere with the
process of bone grafting [106].
For the successful application of scaffolds in tissue engineering, a crucial feature is that the matrices
promote cell adhesion and migration. Takata et al. [107] previously studied the migration of osteoblastic
cells on various guided bone regeneration membranes. Among the membranes tested there are the
bovine type I atelocollagen (Tissue GuideA; TG, Koken, Tokyo, Japan), polylactic acid (Epi-GuideA;
EG, THM Biomedical Inc., Duluth, MN, USA) and co-polymer of cellulose acetate and nitrocellulose
(Millipore filter®; MP, Millipore Co., Billerica, MA, USA). Millipore filter (MP) containing cellulose
showed uniform and enhanced cell migration compared to polylactic acid membrane. Moreover,
MP showed the greatest amount of cells attached as compared to other membranes. Based on these
preliminary data it appears that MP may be particularly useful to guide bone regeneration [107].
BC was tested in dental tissue regeneration [108] using the “otolith/collagen/BC nanocomposites”
as a scaffold for bone regeneration. BC produced by the Gram-negative acetic acid bacteria
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Gluconacetobacter xylinus, consists of an ultra-fine gel network of cellulose nanofibres (3–8 nm).
The “otolith/collagen/bacterial cellulose nanocomposites” was fabricated by immersion of dried
BC into nanotolith gels and posterior soft drying at 50 ◦C for 12 h. Cell adhesion was verified by
4,6-diamidino-2-phenylindole (DAPI) staining. The results showed that the fermentation process
and nanotoliths agglomeration decreased initial human dental pulp stem cell adhesion. However,
it increased cell viability over time and demonstrated the potential of being an effective scaffold for
bone and tissue regeneration [108].
Table 5. Summary of the cellulose-based materials tested in dental applications.
Type of Cellulose Characteristics Applications References
GIC with NFC from
eucalyptus pulp
length (L) and diameter (D) of the
isolated nanocellulose were
determined to be 145 ± 25 nm and
6 ± 1.5 nm, respectively, with an
aspect ratio (L/D) of 24.
reinforcing agent in dental
restorative material Silva et al. [99]
Ramie fiber extracted from the phloemtissue of the plant
reinforcing agent for denture
base resin with higher flexural
modulus, but weak
interfacial adhesion
Xua et al. [103]
Collagen and polylactic acid Resorbable membrane barriers
disallowing of fast-growing
gum tissue from getting into
the regenerative site
Fassman, A. et al. [106]
Ethyl cellulose Non resorbable membrane barriers
disallowing of fast-growing
gum tissue from getting into
the regenerative site
Fassman, A. et al. [106]
MP containing cellulose co-polymer of celluloseacetate and nitrocellulose
uniform and enhanced cell
migration in bone
regeneration
Takata, T. et al. [107]
Polylactic-acid membrane
Less uniform and enhanced
cell migration in bone
regeneration than MP
Takata, T. et al. [107]
otolith/collagen/bacterial
cellulose nanocomposites
Cellulose from bacteria
Gluconacetobacter xylinus; ultra-fine gel
network of cellulose nanofibres
(3–8 nm), with nanotolith gels.
Good scaffold for bone and
tissue regeneration Olyveira, G. et al. [108]
MP = Millipore filter; GIC = Glass ionomer cement.
5.5. Other Applications
In general, the nano cellulose containing materials employed in the applications below described
(Table 6) are used with the intent not to persist in the biological environment for very long time, rather
to be subsequently degraded after having completed their function.
5.5.1. Cancer Diseases
In a recent work [109], NFC aerogel has been loaded with the hydrophilic drug bendamustine,
a nitrogen mustard compound that functions as an alkylating antineoplastic agent. The drug is used in
the therapy of chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin’s lymphoma. NFC
was used because of the good flexibility, elasticity, low toxicity, the ability to swell in water and to host
hydrophilic compounds. For NFC hydrogel, swelling was pH dependent being maximal at pH = 7.4 and
minimum at 1.2 in vitro. Notably the increased swelling observed at pH 7.4 was associated with increased
drug release. The authors also observed that the drug loading capacity directly correlates with the fiber
concentration in the hydrogel. Moreover, in rats, following oral administration, it was observed that the
plasma concentration greatly differed over time between the marketed formulation of bendamustine and
the one newly developed. In the first case, the drug reached a concentration peak after less than an hour
and almost completely disappeared within 5 h from administration. In contrast, with the NFC formulation,
the peak was reached about 5 h after administration and detectable levels of drug were present up to 24 h
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after administration. This kinetic profile clearly shows the great potential of NFC hydrogel in ameliorating
drug release kinetic. These data open the possibility to prepare a long lasting/controlled delivery approach
for the antineoplastic agent bendamustine and possible other similar drugs.
There is a great interest in the development of colon-specific drug delivery systems for the
treatment of many colon-related diseases such as colon cancer and inflammatory diseases. Usually,
films based on natural polymers are employed. However often these films suffer from poor mechanical
barrier and thermal properties. To overcome these limitations, recently it has been proposed the use of
plant NFC. In particular, NFC has been undertaken to reinforce films made by resistant starch (RS) and
Pectin (P), a natural hetero-polysaccharide found in different plant species [110]. As delivered drug,
it has been considered Methotrexate (MTX), a poorly water-soluble drug, with important therapeutic
effects on bowel inflammatory diseases and colorectal cancer. The addition of NFC to RS/P significantly
improved film strength; this fact can be related to the intrinsic rigidity of NFC. Moreover, in an ex vivo
bio-adhesion test employing porcine colonic mucosa sections, NFC improved film muco-adhesion.
In addition, NFC improved the barrier properties towards water penetration compared to control films;
in particular, water permeability was about four times lower. The reduction in water permeability is a
desired feature as high permeability can negatively interfere with the film permanence on the colon
mucosa and alter drug delivery kinetic. Finally, in vitro, NFC was able to increase MTX delivery from
the film. This is a desirable feature as it can contribute to overcome the known oral bioavailability
problems of a poorly soluble drug such as MTX.
Metastasis prevention and inhibition represents one of the major goal for any anticancer therapy.
The implantation in the peri-tumor region of nanofibers mimicking the structure of the ECM proteins
may decrease the risk of tumor cell evasion from their original site. This is probably because nanofiber
and ECM have similar architecture and physical barrier properties [111]. Moreover, nanofibers can
act as cell-adhesive ECM. Based on these considerations, NFCs were prepared and tested for their
anti-metastatic potential [112]. Due to the ability to form matrices, NFCs were also loaded with
the anti-cancer and anti-metastatic drug metformin (Met). In in vitro models of cell migration and
adhesion, the Met-NFC gel was able to effectively reducing the migration, invasion and promoting
adhesion of the melanoma cells B16F10. Notably at the concentration used (17.6 mg/mL), no toxic
effects of Met-NFC were observed for the non-cancerous mouse fibroblasts cells L929. Further tests in
more complex systems will clarify the potential therapeutic value of the Met-NFC gel.
The above examples have considered the use of native not chemically modified nano cellulose
materials. However, chemically modified nano cellulose materials have been also employed in the
approach to cancer diseases. As an example, we mention in this section HPMC. Radiotherapy is
commonly used for the management of malignant pelvic diseases. However, radiotherapy has high
toxicity on surrounding healthy tissues such as the small intestine, colon and rectum. The intravenous
injection of hASC has been observed to reduce severe colorectal lesions caused by ionizing irradiation.
However, a large number of hASC are necessary to obtain beneficial effects. Indeed, among the huge
amount of injected cells, only a minor fraction reaches and engrafts the irradiated intestine [113].
To optimize hASC local delivery, hydrogels have been considered particularly suited. A hydrogel
has been prepared by combining silane, an inorganic compound, with HPMC (Si-HPMC) [114].
The presence of silane was required to confer to the hydrogel the rheological properties suitable
to allow administration via colonoscope. HPMC has been undertaken because of its suitable biological
characteristics and the ability to host human cells. The Si-HPMC hydrogel is biocompatible, maintains
hASC phenotype, viability and protects hASC from the deleterious irradiated environment. Moreover,
in a rat model of radiation-induced severe colonic damage, hASC/Si-HPMC delivered via a colonoscope
catheter, improved colonic biological conditions compared to hASC injected intravenously or locally.
5.5.2. Other Diseases
Small interfering RNAs (siRNAs), belongs to the class of nucleic acid based drugs (NABD),
biological molecules with high therapeutic potential [115–122]. siRNAs are short, double stranded
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RNA molecules (~22 nucleotides) of natural origin that can be also artificially generated. siRNAs
have the ability to specifically target RNA molecules thus inducing their degradation [123]. When
directed against disease-causing RNAs, siRNAs display potent therapeutic effects. Thus, siRNAs
represent novel biological drugs with a remarkable therapeutic potential. However, their chemical
nature does not allow the delivery to the diseased cells as naked molecules. Indeed, in the naked
form, these molecules are rapidly degraded in the extracellular and intracellular environment [124].
Thus, delivery systems able to protect them from degradation are necessary to allow their therapeutic
action [71,125]. A novel system based on the use of CNC has been recently developed [126] for siRNA
delivery. Plant derived CNC has been chosen for being biodegradable, non-toxic and for being able to
target tumors via the EPR effect (Enhanced Permeability and Retention) [127]. The presence of negative
surface charges on CNC limits the interaction with the negatively charged siRNAs. To overcome this
limitation, CNC has been covalently attached to PEI. The great number of positive charges of PEI,
which largely surpassed the negative charges carried by CNC, allowed the electrostatic interactions
with the negatively charged siRNAs (see Figure 11). Moreover, PEI enhances the uptake of associated
particles into cells by endocytosis. The generated CNC-PEI nanoparticles provided efficient protection
of siRNA vs. degradation. Additionally, they allowed efficient uptake in C2C12 murine myoblast.
Moreover, the CNC-PEI nanoparticles carrying a siRNA that targets a cell cycle promoting gene, were
able to effectively down regulating the growth of C2C12. Future studies in more complex animal
models will contribute to fully determining the delivery effectiveness of this CNC-based delivery
system for siRNAs. Obviously, the proposed delivery system loaded with anti-proliferative siRNAs
has the potential to be used in the many forms of human diseases that bases their pathogenicity on the
exaggerated cell proliferation.
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In addition to the systemic delivery of siRNAs above presented, also local delivery is of therapeutic
interest. For example, recently, it has been developed a siRNA topical vaginal sustained delivery
system [128]. This local delivery presents a significant challenge due to the short residence time
of formulations. Thus, a system capable to adhere to the vaginal mucosa is necessary to prolong
delivery and increase the effectiveness of the therapy. To this end, a model siRNA was complexed into
liposomes, lipid particles able to effectively protecting siRNA from degradation and to promote cell
uptake [129]. However, liposomes alone are not suitable for efficient siRNA delivery due to the poor
ability to penetrate through the vaginal mucus and the short residence time. To minimize the first
limitation, liposomes have been coated by polyethylene glycol (PEG). This is a neutral hydrophilic
polymer able to allow efficient mucus penetration due to the ability to reduce adhesive interactions
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between nanoparticles and mucus components. To improve the residence time, liposome-PEG
compounds were incorporated into a hydrogel constituted by hydroxyethyl cellulose (HEC), a material
chosen for its muco-adhesive properties [130]. Notably, HEC concentration in the gel containing
liposome-PEG-siRNA, was directly correlated with the muco-adhesive properties. In contrast,
liposome-PEG-siRNA did not influence the muco-adhesive capacity. Additionally, gel hardness
was directly correlated with HEC concentration but not with liposome-PEG-siRNA amounts. In an
in vitro delivery test, high HEC concentration (1.67% HEC) resulted in a delayed delivery compared to
low concertation (0.83% HEC). This indicates the possibility to tune delivery in relation to the desired
kinetic. Whereas future in vivo studies are necessary to fully elucidating the potential of the developed
delivery system, it is clear the important contribution of HEC in this kind of delivery strategy.
Table 6. Summary of the nano cellulose-based materials tested in “other applications”.
Type of
Cellulose
Material
Realesed In Vitro Tests In Vivo Tests Molecular Effects References
NFC Bendamustine Swelling testsat different pH Rat model Good drug loading and release Bhandari et al. [109]
NFC/RS/P Methotrexate In vitro: good delivery andpermanence in the colon mucosa Meneguin et al. [110]
NFC Metformin B16F10 cells Reduction of the migration, invasionand ashesion of B16F10 cells Nurani et al. [112]
Si-HPMC hASCs Rat model Colonic biological conditionsimproving in rats with colon damage Moussa et al. [114]
CNC-PEI siRNA C2C12 murinemyoblastic cells
Decrease of the cells growth
(anti-proliferative)
Ndong
Ntoutoume et al. [126]
HEC-PEG siRNA Muco-adhesive properties Furst et al. [128]
CMC/β-C/AA Acyclovir Swelling testsat different pH
Basic pH favors the maximal swelling
of the CMC/β-C/AA releasing
acyclovir in the small intestine
Malik et al. [131]
NFC = Cellulose in form of nanofibers; Si-HPMC = silane-hydroxyl-propylmethyl cellulose; hASC = human
adipose mesenchymal stem cells; NFC/RS/P = cellulose nanofibrils/resistant starch/pectin; CMC/β-C/AA
= CMC/β-cyclodextrin/acrylic acid; EC-MC = ethyl cellulose-methyl cellulose; CNC-PEI = cellulose
nanocrystals-Polyethylenimine; HEC-PEG = hydroxyethyl cellulose-polyethylene glycol; siRNA = small
interference RNA.
Acyclovir is an antiviral drug able to down regulating herpes simplex virus (HSV) replication.
HSV is typically responsible for different form of human diseases such as herpes labialis and herpes
zoster. To get the desired therapeutic effects, acyclovir has to be administered via oral/systemic route
using multiple administrations of large doses, which are often plagued by significant side effects.
Recently, to optimize acyclovir delivery it has been developed a novel hydrogel composed by CMC,
β-cyclodextrin (β-C) and acrylic acid (AA) [131]. CMC has been undertaken due to its excellent
biocompatibility, biodegradability, low immunogenicity and ability to swell. B-C are natural, cyclic
oligosaccharides, composed of between six and eight glucose units [71,72]. They are used as drug
carriers especially due to the ability to host a large number of drug molecules. AA has remarkable
bio-adhesion, pH responsive and mechanical properties. The authors observed that hydrogel swelling,
one of the most relevant property for controlled drug delivery, was dependent on CMC amount.
In particular, swelling was maximal using a CMC amount in the hydrogel of 12 (%w/w). Moreover,
swelling was pH dependent being maximal at pH = 7.4 and minimum at 1.2 in vitro. Despite no
experiments have been performed in living models, it is assumable that following oral administration,
maximum swelling and thus acyclovir delivery occurs in the small intestine. Here, the more basic pH
compared to the stomach, should favor acyclovir release from the hydrogel.
5.6. Clinical Trials
Applications of nano cellulose are not limited to preclinical testing, examples exist (Table 7) of the
close use in the clinic as shown by the clinical trials below reported.
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Nanoparticles of appropriate sizes and stability can be pushed into hair follicles via a gear pump
mechanism [132]. Thus, such nanoparticles can potentially be used to deliver anti acne drugs directly
to the acne-affected follicles. To achieve this goal, ethyl cellulose-methyl cellulose (EC-MC) has been
used to fabricate nanoparticles able to deliver the anti-acne compound α-mangostin [133]. EC-MC
was used because of the very low price, biocompatibility and the possibility to fabricate nanoparticles
with excellent drug loading capacity [134]. When embedded into EC-CM, α-mangostin was released
in synthetic sebum up to 168 h with 50% delivery being reached after about 8 h.
Table 7. Summary of the nano-cellulose-based material tested in clinical trials.
Type of Cellulose Strategy Effect References
EC-MC Delivery α-mangostin compound Anti-acne effect Pan-In et al. [133]
HA-CMC HA-CMC soaked with Gelfoam Hearing improvement withoutsignificant collateral effects Ahn et al. [135]
HA-CMC Artificial tears composed ofhyaluronate 0.1% and CMC 0.5%
Improvement of the tear-film in
eyes after cataract surgery Mencucci et al. [136]
HPMC Delivery oxymetazoline compound Improvement of mucosalbarrier in allergic rhinitis Valerieva et al. [137]
EC-MC: ethyl cellulose-methyl cellulose; HA-CMC: sodium hyaluronate (HA) and CMC; HPMC:
hydroxypropylmethylcellulose.
Importantly, EC-CM nanoparticles did not trigger any significant skin inflammatory reactions as
evaluated by a two-week, twice-daily application in 20 healthy human volunteers. Successful delivery
of α-mangostin was proven following drug quantification in the roots of hairs obtained from the skin
of six human volunteers topically treated. Finally, following a 4 week-randomized, double-blind,
placebo-controlled study in 10 acne patients, it was possible to observe significant improvement in acne
in correspondence of the portion of skin treated by the α-mangostin containing EC-CM nanoparticles.
The middle-ear packing material represents one of the key elements in the success of
tympanomastoid surgery. This material provides support for tympanoplasty graft. Often, resorbable
gelatin is used for this purpose. However, adverse effects such as fibrosis resulting in suboptimal
hearing outcomes, plagues the use of gelatin. To overcome this problem it has been proposed the
use of sodium hyaluronate (HA) and CMC [135]. HA is an inert and safe glycosaminoglycan easy to
use and able to remain at the desired biological site for long period. CMC has been used as viscosity
thickener of the emulsion of HA-CMC. Notably, HA-CMC is bioresorbable and can significantly
reduce the postoperative adhesion. HA-CMC has been added to Gelfoam, a sterile compressed
prepared from purified porcine skin, Gelatin and water. One hundred forty three patients with
chronic otitis media that underwent tympanoplasty, were treated with Gelfoam soaked in HA-CMC;
another 144 patient were instead treated with Gelfoam alone. The result of this clinical trial indicates
that HA-CMC-Gelfoam treated patients had better postoperative hearing improvement and reduced
complications. The authors suggested that this was most likely due to the better anti inflammatory
and anti-adhesive properties of HA-CMC-Gelfoam compared to Gelfoam alone.
CMC has found also another interesting application in the preparation of artificial tears [136].
In particular, it has been studied the effectiveness of sodium hyaluronate 0.1% and CMC 0.5% artificial
tears to attenuate ocular discomfort and improve tear-film stability in eyes after cataract surgery. CMC
was used because of its good bio-adhesive characteristics [138] and because of its anionic nature that is
beneficial in increasing tear retention time [139]. HA, a glycosaminoglycan disaccharide biopolymer
composed of repeating alternating sequences of N-acetylglucosamine and glucuronate in linear chains,
has the ability to bind water molecules and prevent dehydration. Two hundreds and eighty two
patients were divided into two groups: after surgery, the first received artificial tears and a topical
steroid-antibiotic (study group), while the second just topical steroid-antibiotic alone (control group).
The patients were then evaluated post-operatively at 1 and 5 weeks by tear breakup time (TBUT) and
Corneal fluorescein staining (CFS). TBUT, a clinical test used to evaluate evaporative dry eye disease,
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is measured following fluorescein instillation into the patient’s tear film asking the patient not to blink
while the tear film is observed under a broad beam of cobalt blue illumination. The TBUT is recorded
as the number of seconds that elapse between the last blink and the appearance of the first dry spot
in the tear film. CFS is performed by touching a piece of blotting paper containing fluorescein to the
surface of patient eye. The patient is then asked to blink to spread the dye in the tear film thus covering
the surface of the cornea. By looking at the patient eye with a blue light, it is possible to detect any
problems on the surface of the cornea, which will be stained by fluorescein (green dye). At 5 weeks,
the mean TBUT and CFS were statistically significantly higher and lower, respectively, in the study
group compared to the control group. Importantly, the hyaluronate 0.1% and CMC 0.5% artificial tears
were well tolerated by the patients. Thus HA and CMC seem to be very promising components of
artificial tear as also witnessed by the fact that they are the two most commonly prescribed and used
substances for dry eye disorders [139].
In another interesting clinical trial, hydroxypropylmethylcellulose (HPMC) was tested in the
treatment of allergic rhinitis [137]. It has been hypothesized that inhaled allergens, as well as other
substances, can disrupt the integrity of nasal mucosal lining thus favoring the contact of the body with
external harmful agents. Over time, this can result in the development of allergic rhinitis characterized
by persistent inflammation and mucosal congestion. This in turn brings to a variable degree of nasal air
flow reduction and discomfort for the patient. To down regulate inflammation and mucosal congestion,
decongestant substances such as oxymetazoline nasal spray, 0.05% are often used. Recently, HPMC
has been employed in addition to oxymetazoline [137] due to its known mucoprotective effects based
on its viscoelastic properties. Forty allergic rhinitis patients were divided into two groups: the first
was locally treated by oxymetazoline, followed by HPMC, the second was treated similarly but instead
of HPMC, lactose powder (placebo) was administered. The treatment was performed twice a day for 7
days followed by oxymetazoline rescue medication for another week. Treatment effects were measured
by evaluating the peak inspiratory nasal flow (PNIF) which reflects the nasal patency. Baseline PNIF
was greater in the HPMC group at day 15 reflecting a more marked reduction in nasal congestion.
The authors suggest that this effect may be due to the HPMC muco-adhesion properties which can
improve the mucosal barrier in allergic rhinitis thus limiting the contact with allergens.
In addition to the above clinical trials, it should be also noted that BC-based materials are already
on the market for different applications approved by FDA. In this regard, BC derived materials are
used in vessel implants, in the fabrication of artificial skin and in wound care systems [140].
6. Conclusions
Due to its biocompatibility, bio-degradability, low-cost and easy availability, nano-cellulose finds
application in disparate research fields. In the biomedical field, scientists can take advantage of the
strength of nano cellulose that rends it suitable in different applications such as bone regeneration.
In this regard, the works mentioned in the review indicate how nano cellulose and its chemical
derivatives have the potential to allow the hosting of various types of progenitor stem cells. These
cells can differentiate into the nano cellulose matrix giving origin to osteogenic cells thus promoting
ossification. However, the beneficial effects of nano cellulose are not limited to this aspect. Indeed,
nano cellulose can improve the formation of new capillaries, essential to provide nutrients and oxygen
to the newly developed bone. Moreover, nano cellulose combined with other substance, has the
potential to favor the deposition of calcium phosphate crystals, pivotal components of the bone.
Not only is nano cellulose suited for the (re)generation of hard tissues such as bone, when
appropriately combined with other substances like alginates, it can be used to generate soft materials
such as “bionk” for cartilage reconstitution. This impressive material combines the properties of nano
cellulose with those of alginates giving origin to a novel compound with the appropriate features in
terms of rheology, compression and shape deformation suitable to be used as bionk. Always in the
field of soft tissue regeneration, nano cellulose finds potential advantages also in the wound healing
field. Here, nano cellulose in combination with different materials can promote skin regeneration
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in different ways. In particular, it can favor hASC adhesion/proliferation, combat bacterial growth
and promote angiogenesis. Together all these properties promote proper and fast healing. This is
particularly important for extended skin lesion caused by thermal sources where bacterial infections
and excessive fluid loss can lead to patient death if the skin is not rapidly regenerated.
Nano cellulose materials have also the potential to be used as drug delivery compounds.
A noticeable example described in this review includes the systemic (oral) delivery of the anticancer
drug bendamustine. The nano cellulose-based material developed may allow a long lasting/controlled
delivery that may permit to improve drug effectiveness reducing side effects. In addition to systemic
delivery, also local delivery has been explored with nano cellulose-based materials. Here, for example,
we mention the colon-specific delivery of the anticancer drug Methotrexate. The nano cellulose-based
materials in the form of gel is able to properly adhere to the colon mucosa and to create a barrier
against water penetration, thus favoring gel permanence and drug local delivery.
The potential use of nano cellulose-based materials as drug delivery devices is not limited
to conventional FDA approved drugs; it extends also to novel classes of drugs such as siRNAs.
Despite being potentially very effective, siRNAs suffer from the poor stability when delivered into
the biological environment. Nano cellulose-based materials have the ability to provide efficient
protection from degradation also improving effective cellular uptake. The only drawback of nano
cellulose-based materials is that they are negatively charged and thus in the native form cannot bind
the negatively charged siRNAs. To overcome this limitation, positively molecules are combined with
nano cellulose-based materials thus allowing siRNA binding.
Finally, nano cellulose-based materials are not far from the practical use as shown by the clinical
trials mentioned in this review in different the fields such as hearing improvement, cataract surgery and
the improvement of mucosal barrier in allergic rhinitis. Moreover, nano cellulose-based materials find
practical application in vessel implants, in the fabrication of artificial skin and in wound care systems.
For medical applications, it seems BC to be preferable to PC as BC does not contain lignin,
hemicellulose structures and its preparation does not need any chemical synthesis and/or treatments.
Moreover, purified BC has a content of endotoxin falling within the acceptable range indicated by FDA.
Finally, an open aspect in the use of nano cellulose materials concerns the employment of chemical
modifications in relation to safety. In this respect, even if preliminary tests in animal models seem to
be comforting, it will be pivotal to know how regulatory agencies will consider these materials.
Altogether, the examples of nano cellulose applications here reported strongly support the
enormous application potential of this material whose relevance includes, but is not limited to,
the biomedical field.
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